Reuters logo
BRIEF-Ultragenyx Pharmaceutical comments on Dimension Therapeutics' announcement
October 2, 2017 / 1:42 PM / 20 days ago

BRIEF-Ultragenyx Pharmaceutical comments on Dimension Therapeutics' announcement

Oct 2 (Reuters) - Ultragenyx Pharmaceutical:

* Ultragenyx Pharmaceutical comments on dimension therapeutics’ announcement that co’s offer is a “superior proposal” in its merger agreement with regenxbio

* Ultragenyx Pharmaceutical says is “pleased” that dimension board determined that all-cash offer to buy dimension for $6.00 per share is a superior proposal Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below